In addition, there was no T cell activation for the non-cognate tumor cell line (K562 cell or CEA+ K562 cell) in contrast to the significant activation for cognate tumor cells (MSLN+ K562), thereby showing specific targeting activity of sdCAR-T cells. This evidence concerns the gene MSLN and neoplasm.